US Edition
The clinical trial innovation surge
Summary by European Pharmaceutical Manufacturer
This story is only covered by news sources that have yet to be evaluated by the independent media monitoring agencies we use to assess the quality and reliability of news outlets on our platform. Learn more here.2 Articles
2 Articles
All
Left
Center
Right
The National Medicines Agency is launching a platform through which any patient can enroll in a clinical trial, depending on the condition they have. The advantage for patients is that they can benefit from innovative treatments for their diseases, before the drug is reimbursed on the national list.
·Romania
Read Full Article
Coverage Details
Total News Sources2
Leaning Left0Leaning Right0Center0Last UpdatedBias DistributionNo sources with tracked biases.
Bias Distribution
- There is no tracked Bias information for the sources covering this story.
Factuality
To view factuality data please Upgrade to Premium
